Published on: March 26, 2025
Because of its high-acuity patient population and intensive resource requirements, TAVR is often seen as an economically unappealing procedure option. To address these concerns, Baylor Scott and White Health’s (BSWH’s) leadership explore the broader financial impact of TAVR to uncover the hidden value beyond the procedure itself. By exploring the broader advantages, BSWH shifts the narrative surrounding TAVR from loss to strategic growth. This session explores their approach and lessons learned, emphasizing collaboration, data governance and iterative improvement as part of BSWH’s roadmap for success.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.